Molecular Therapy: Difference between revisions
Content deleted Content added
Updated 2020 impact factor based on the Journal's website. https://www.cell.com/molecular-therapy-family/aims |
No edit summary Tags: Mobile edit Mobile web edit |
||
Line 16: | Line 16: | ||
| openaccess = |
| openaccess = |
||
| license = |
| license = |
||
| impact = |
| impact = 12.9 |
||
| impact-year = |
| impact-year = 2022 |
||
| ISSNlabel = |
| ISSNlabel = |
||
| ISSN = 1525-0016 |
| ISSN = 1525-0016 |
||
Line 34: | Line 34: | ||
The founder of the journal and its Editor-in-Chief in the first five years was [[Inder Verma]].<ref>{{Cite web|url=https://www.salk.edu/news-release/salk-scientist-inder-verma-to-receive-2009-outstanding-achievement-award-from-american-society-of-gene-therapy/|title = Salk Scientist Inder Verma to Receive 2009 Outstanding Achievement Award from American Society of Gene Therapy}}</ref> |
The founder of the journal and its Editor-in-Chief in the first five years was [[Inder Verma]].<ref>{{Cite web|url=https://www.salk.edu/news-release/salk-scientist-inder-verma-to-receive-2009-outstanding-achievement-award-from-american-society-of-gene-therapy/|title = Salk Scientist Inder Verma to Receive 2009 Outstanding Achievement Award from American Society of Gene Therapy}}</ref> |
||
== References == |
== References == |
||
{{reflist}} |
{{reflist}} |
Revision as of 09:23, 1 March 2023
Discipline | Genetic diseases |
---|---|
Language | English |
Edited by | Seppo Ylä-Herttuala |
Publication details | |
History | 2000–present |
Publisher | |
Frequency | Monthly |
12.9 (2022) | |
Standard abbreviations | |
ISO 4 | Mol. Ther. |
Indexing | |
ISSN | 1525-0016 (print) 1525-0024 (web) |
OCLC no. | 41354718 |
Links | |
Molecular Therapy is a scientific journal, published by Cell Press, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases".[1]
The founder of the journal and its Editor-in-Chief in the first five years was Inder Verma.[2]
References
External links